Drug management

Drug pricing & markets, value-based pricing, cost control, real-world evidence for safety and effectiveness

Drug management
Generics of the Authorized Kind
Frieda Wiley
They can add competition and lower prices, but some see authorized generics as a ploy to fend off competition from true generics.
Drug management
Prime Sees Dip in Opioids, Triptans as CGRP Inhibitor Scripts Take Off
Thomas Reinke
But discontinuation rate is high, and Wall Street is unimpressed by sales of the new class of migraine medications.
Drug management
Some State Medicaid Programs Still Block or Limit Hep C Drugs
Ed Silverman
Restrictions blunted the effect of Sovaldi and other antivirals on Medicaid budgets. The gradual removal of these barriers is going too slowly, say advocates.
Drug management
New Generics Wait Too Long To Get on Formularies, Says Trade Group
Ed Silverman
Generic medicines are touted as a cost-saving tool, but formulary tactics stand in their way. A new report from the Association for Accessible Medicines says years can pass between FDA approval of a “first generic” and its inclusion on a majority of Part D plan formularies.
Drug management
Evidence Mounts for IL-23 and IL-17 Inhibitors As Treatment for Psoriasis
Thomas Reinke
The TNF inhibitors have ruled the roost, and Humira is the top selling drug in the world. But the interleukin inhibitors are challenging TNF inhibitor hegemony.
Drug management
International Reference Pricing: A Wee Bit of Political Agreement, a Great Deal of Uncertainty
Timothy Kelley
C​ould drug prices be lowered by pegging them to what is paid in other countries? The Trump administration took a step in that direction last fall, when CMS floated a proposal to use international reference pricing (IRP)—average prices paid in a select group of other high-income nations—to limit…
Drug management
Spread Pricing: From Largely Unknown To Much Scrutinized and Criticized
Ed Silverman
After Ohio uncovered huge spreads, other states have taken a hard look at spread pricing in their Medicaid programs. U.S. senators and CMS are also getting into the act.
Drug management
Specialty Drug Spend Soars. Can Formulary Management Bring It Down to Earth? 
Thomas Reinke
Utilization management techniques for traditional medicines don’t translate to drugs covered by the medical benefit. Site-of-service programs show some promise, though.
Cancer Screening Initiatives

A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives

View Supplement
P&T Product Profiler

ZULRESSO™ (brexanolone) injection CIV

View Supplement
Clinical Brief

Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report

View Supplement
© 2019 MediMedia, an ICON plc company. All rights reserved.